JP2023015334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023015334A5 JP2023015334A5 JP2022184220A JP2022184220A JP2023015334A5 JP 2023015334 A5 JP2023015334 A5 JP 2023015334A5 JP 2022184220 A JP2022184220 A JP 2022184220A JP 2022184220 A JP2022184220 A JP 2022184220A JP 2023015334 A5 JP2023015334 A5 JP 2023015334A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- propylene glycol
- acid
- fatty acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021079015 | 2021-05-07 | ||
| JP2021079015 | 2021-05-07 | ||
| PCT/JP2022/019540 WO2022234850A1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
| JP2022548967A JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Division JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023015334A JP2023015334A (ja) | 2023-01-31 |
| JP2023015334A5 true JP2023015334A5 (enExample) | 2025-05-16 |
Family
ID=83932759
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Active JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
| JP2022184220A Withdrawn JP2023015334A (ja) | 2021-05-07 | 2022-11-17 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Active JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240366711A1 (enExample) |
| EP (1) | EP4299069A4 (enExample) |
| JP (2) | JP7181442B1 (enExample) |
| KR (2) | KR20230169093A (enExample) |
| CN (1) | CN117241817A (enExample) |
| AU (1) | AU2022270498A1 (enExample) |
| BR (1) | BR112023019622A2 (enExample) |
| CA (1) | CA3219090A1 (enExample) |
| IL (1) | IL306018A (enExample) |
| MX (1) | MX2023013099A (enExample) |
| TW (1) | TW202308679A (enExample) |
| WO (1) | WO2022234850A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI852183B (zh) | 2011-12-28 | 2024-08-11 | 日商中外製藥股份有限公司 | 胜肽化合物之環化方法 |
| EP4043478A4 (en) | 2019-11-07 | 2024-01-03 | Chugai Seiyaku Kabushiki Kaisha | CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION |
| AR125800A1 (es) | 2021-05-07 | 2023-08-16 | Chugai Pharmaceutical Co Ltd | Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n |
| IL316253A (en) | 2022-05-06 | 2025-01-01 | Chugai Pharmaceutical Co Ltd | A cyclic compound with selective KRAS inhibitory effect on HRAS and NRAS |
| US20260132169A1 (en) * | 2022-10-20 | 2026-05-14 | Chugai Seiyaku Kabushiki Kaisha | Method for producing cyclic peptide crystals |
| TW202506706A (zh) * | 2023-04-20 | 2025-02-16 | 日商中外製藥股份有限公司 | 環狀胜肽化合物的製造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012112319A1 (en) * | 2011-02-04 | 2012-08-23 | Aegis Therapeutics, Llc | Orally bioavailable peptide drug compositions and methods thereof |
| ES2586411T3 (es) | 2011-03-04 | 2016-10-14 | New York University | Macrociclos sustitutos de enlace de hidrógeno como moduladores de Ras |
| TWI852183B (zh) * | 2011-12-28 | 2024-08-11 | 日商中外製藥股份有限公司 | 胜肽化合物之環化方法 |
| WO2016071515A1 (en) | 2014-11-07 | 2016-05-12 | Sigmoid Pharma Limited | Compositions comprising cyclosporin |
| EP3442991A4 (en) | 2016-04-15 | 2019-11-20 | RA Pharmaceuticals, Inc. | RAS-BINDING PEPTIDES AND METHODS OF USE |
| US10808010B2 (en) | 2016-08-11 | 2020-10-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptide inhibitors of phosphoglycerate mutase and methods of use |
| EP3636807A4 (en) | 2017-06-09 | 2021-07-28 | Chugai Seiyaku Kabushiki Kaisha | CYCLIC PEPTIDE COMPOUND WITH HIGH MEMBRANE PERMEABILITY AND LIBRARY WITH IT |
| WO2020122182A1 (ja) | 2018-12-12 | 2020-06-18 | 中外製薬株式会社 | 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法 |
| EP4043478A4 (en) * | 2019-11-07 | 2024-01-03 | Chugai Seiyaku Kabushiki Kaisha | CYCLIC PEPTIDE COMPOUND HAVING KRAS INHIBITING ACTION |
| AR125800A1 (es) * | 2021-05-07 | 2023-08-16 | Chugai Pharmaceutical Co Ltd | Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n |
-
2022
- 2022-05-06 KR KR1020237032063A patent/KR20230169093A/ko not_active Withdrawn
- 2022-05-06 TW TW111117094A patent/TW202308679A/zh unknown
- 2022-05-06 CN CN202280029838.6A patent/CN117241817A/zh active Pending
- 2022-05-06 MX MX2023013099A patent/MX2023013099A/es unknown
- 2022-05-06 BR BR112023019622A patent/BR112023019622A2/pt unknown
- 2022-05-06 KR KR1020237001877A patent/KR102582225B1/ko active Active
- 2022-05-06 US US18/289,392 patent/US20240366711A1/en not_active Abandoned
- 2022-05-06 AU AU2022270498A patent/AU2022270498A1/en not_active Abandoned
- 2022-05-06 EP EP22798954.8A patent/EP4299069A4/en not_active Withdrawn
- 2022-05-06 CA CA3219090A patent/CA3219090A1/en active Pending
- 2022-05-06 JP JP2022548967A patent/JP7181442B1/ja active Active
- 2022-05-06 WO PCT/JP2022/019540 patent/WO2022234850A1/ja not_active Ceased
- 2022-05-06 IL IL306018A patent/IL306018A/en unknown
- 2022-11-17 JP JP2022184220A patent/JP2023015334A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2022234850A5 (enExample) | ||
| JP4636692B2 (ja) | 長鎖トリグリセリドと親油性界面活性剤とを含有する経口医薬組成物 | |
| Yang et al. | The effect of oil type on the aggregation stability of nanostructured lipid carriers | |
| TWI358268B (enExample) | ||
| Gibson | Lipid-based excipients for oral drug delivery | |
| JP6896019B2 (ja) | 脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法 | |
| CA2494762A1 (en) | Pharmaceutical compositions comprising cyclosporin for oral administration | |
| US20090149533A1 (en) | Novel fenofibrate formulations and related methods of treatment | |
| CA2494796A1 (en) | Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant | |
| JP2021504468A5 (enExample) | ||
| CN117126069A (zh) | 具有改善的稳定性的制剂 | |
| WO2015186040A1 (en) | Stable nanoemulsion composition | |
| CN114073681A (zh) | 一种含有多廿烷醇的胶囊内容物及其制备方法和软胶囊剂 | |
| JPWO2009025372A1 (ja) | 還元型補酵素ｑ１０含有組成物及びその安定化方法 | |
| EP2429510A1 (en) | Oil-in-water emulsion of mometasone and propylene glycol | |
| JP2009542782A (ja) | 活性成分の注射可能な持続放出処方剤、およびその調製方法 | |
| JPH09208986A (ja) | 酸化防止剤製剤 | |
| JP7126930B2 (ja) | ビタミンｅ含有油性組成物 | |
| JP2011152112A (ja) | 豆腐用消泡剤組成物 | |
| JP2017214335A (ja) | コエンザイムｑ１０組成物及びそれが充填されたソフトカプセル | |
| JPH10330250A (ja) | メナテトレノン油性製剤 | |
| GB2541387A (en) | Self-emulsifying Nanosuspensions as Drug Delivery Systems (SENDDS) | |
| EP3236780B1 (en) | Use of lecithin to inhibit the crystallisation of lysin | |
| RU2398577C2 (ru) | Новые композиции фенофибрата и соответствующие способы лечения | |
| WO2019087696A1 (ja) | 経口医薬組成物 |